newsfilter
← Latest News
PR Newswire·

Medivir's patent application for fostrox approved in China

STOCKHOLM, June 19, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today that the